| GPS |
Table GPS-0. Nationwide surveys among the general population: Bibliographic references
|
table |
| GPS |
Table GPS-1. Lifetime prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population
Part (i) Lifetime prevalence all adults
|
table |
| GPS |
Table GPS-1. Lifetime prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population
Part (ii) Survey methods
|
table |
| GPS |
Table GPS-2. Lifetime prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-3. Last year prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-4. Last year prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-5. Last month prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-6. Last month prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-7. Frequency of use of cannabis among all adults (aged 15 to 64 years) and young adults (aged 15 to 34 years) in nationwide surveys among the general population
Part (i) Frequency of use among all users in last month (percentage) — 2007 field trial
|
table |
| GPS |
Table GPS-7. Frequency of use of cannabis among all adults (aged 15 to 64 years old) and young adults (aged 15 to 34 years old) in nationwide surveys among the general population
Part (ii) Frequency of use among all users in last month (percentage) — 2004 field trial
|
table |
| GPS |
Table GPS-8. Lifetime prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population.
Part (i) Lifetime prevalence all adults: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-8. Lifetime prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population.
Part (ii) Survey methods: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-9. Lifetime prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-10. Last year prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-11. Last year prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-12. Last month percentage prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-13. Last month prevalence of drug use among young adults (aged 15 to 34 years) in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-14. Lifetime prevalence of drug use among the 15–24 age group in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-15. Last year prevalence of drug use among the 15–24 age group in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-16. Last month prevalence of drug use among the 15–24 age group in nationwide surveys among the general population
|
table |
| GPS |
Table GPS-17. Lifetime prevalence of drug use among the age group of 15 to 24 years old in nationwide surveys among the general population. Last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-18. Last year prevalence of drug use among the 15–24 age group in nationwide surveys among the general population. Last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-19. Last month prevalence of drug use among the 15–24 age group in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards)
|
table |
| GPS |
Table GPS-121. Methodological information for nation-wide surveys among the general population
|
table |
